Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xwell Inc (XWEL)

Xwell Inc (XWEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xwell Inc 254 WEST 31ST STREET 11TH FLOOR NEW YORK NY 10001 USA

www.xwell.com P: 212-750-9595

Description:

XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 5,940
Enterprise Value, $K -2,500
Shares Outstanding, K 4,183
Annual Sales, $ 30,110 K
Annual Net Income, $ -27,740 K
Last Quarter Sales, $ 7,400 K
Last Quarter Net Income, $ -6,580 K
EBIT, $ -21,190 K
EBITDA, $ -10,850 K
60-Month Beta 2.43
% of Insider Shareholders 4.90%
% of Institutional Shareholders 8.67%
Float, K 3,978
% Float 95.10%
Short Volume Ratio 0.65

Growth:

1-Year Return -68.13%
3-Year Return -93.43%
5-Year Return -98.80%
5-Year Revenue Growth -39.89%
5-Year Earnings Growth 99.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.57 on 04/16/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -5.13
EPS Growth vs. Prev Qtr -106.58%
EPS Growth vs. Prev Year 47.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 09/28/23

XWEL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -65.58%
Return-on-Assets % -41.35%
Profit Margin % -92.13%
Debt/Equity 0.00
Price/Sales 0.19
Price/Cash Flow N/A
Price/Book 0.28
Book Value/Share 5.02
Interest Coverage -0.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar